Zimmermann, P.; Sourij, H.; Aberer, F.; Rilstone, S.; Schierbauer, J.; Moser, O.
SGLT2 Inhibitors in Long COVID Syndrome: Is There a Potential Role? J. Cardiovasc. Dev. Dis. 2023, 10, 478.
https://doi.org/10.3390/jcdd10120478
AMA Style
Zimmermann P, Sourij H, Aberer F, Rilstone S, Schierbauer J, Moser O.
SGLT2 Inhibitors in Long COVID Syndrome: Is There a Potential Role? Journal of Cardiovascular Development and Disease. 2023; 10(12):478.
https://doi.org/10.3390/jcdd10120478
Chicago/Turabian Style
Zimmermann, Paul, Harald Sourij, Felix Aberer, Sian Rilstone, Janis Schierbauer, and Othmar Moser.
2023. "SGLT2 Inhibitors in Long COVID Syndrome: Is There a Potential Role?" Journal of Cardiovascular Development and Disease 10, no. 12: 478.
https://doi.org/10.3390/jcdd10120478
APA Style
Zimmermann, P., Sourij, H., Aberer, F., Rilstone, S., Schierbauer, J., & Moser, O.
(2023). SGLT2 Inhibitors in Long COVID Syndrome: Is There a Potential Role? Journal of Cardiovascular Development and Disease, 10(12), 478.
https://doi.org/10.3390/jcdd10120478